XOMA Royalty Corp (XOMA)
29.86
-0.21
(-0.70%)
USD |
NASDAQ |
Nov 22, 14:53
XOMA Royalty Enterprise Value: 329.43M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 329.43M |
| November 20, 2024 | 328.85M |
| November 19, 2024 | 329.79M |
| November 18, 2024 | 328.73M |
| November 15, 2024 | 331.08M |
| November 14, 2024 | 327.20M |
| November 13, 2024 | 325.19M |
| November 12, 2024 | 343.46M |
| November 11, 2024 | 342.28M |
| November 08, 2024 | 340.04M |
| November 07, 2024 | 330.97M |
| November 06, 2024 | 357.60M |
| November 05, 2024 | 340.63M |
| November 04, 2024 | 338.74M |
| November 01, 2024 | 332.25M |
| October 31, 2024 | 330.14M |
| October 30, 2024 | 326.14M |
| October 29, 2024 | 350.47M |
| October 28, 2024 | 330.37M |
| October 25, 2024 | 322.02M |
| October 24, 2024 | 321.91M |
| October 23, 2024 | 317.44M |
| October 22, 2024 | 311.92M |
| October 21, 2024 | 309.68M |
| October 18, 2024 | 320.73M |
| Date | Value |
|---|---|
| October 17, 2024 | 314.15M |
| October 16, 2024 | 321.67M |
| October 15, 2024 | 312.50M |
| October 14, 2024 | 306.98M |
| October 11, 2024 | 299.46M |
| October 10, 2024 | 290.29M |
| October 09, 2024 | 296.16M |
| October 08, 2024 | 297.81M |
| October 07, 2024 | 297.34M |
| October 04, 2024 | 300.04M |
| October 03, 2024 | 285.47M |
| October 02, 2024 | 296.99M |
| October 01, 2024 | 294.17M |
| September 30, 2024 | 286.41M |
| September 27, 2024 | 280.56M |
| September 26, 2024 | 274.47M |
| September 25, 2024 | 281.85M |
| September 24, 2024 | 291.33M |
| September 23, 2024 | 293.32M |
| September 20, 2024 | 306.19M |
| September 19, 2024 | 325.62M |
| September 18, 2024 | 311.69M |
| September 17, 2024 | 310.99M |
| September 16, 2024 | 310.99M |
| September 13, 2024 | 315.44M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
98.41M
Minimum
Sep 13 2022
486.94M
Maximum
Dec 21 2020
219.62M
Average
202.18M
Median
Jan 18 2023
Enterprise Value Benchmarks
| Twist Bioscience Corp | 2.196B |
| Dynavax Technologies Corp | 1.084B |
| NovaBay Pharmaceuticals Inc | 2.798M |
| Palatin Technologies Inc | 15.96M |
| iBio Inc | 12.31M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -17.24M |
| Revenue (Quarterly) | 0.734M |
| Total Expenses (Quarterly) | 2.374M |
| EPS Diluted (Quarterly) | -1.59 |
| Profit Margin (Quarterly) | -2.35K% |
| Earnings Yield | -11.65% |
| Normalized Earnings Yield | -7.801 |